Baker Brothers Advisors - FOAMIX PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2019$1,514,000
+27.7%
498,1890.0%0.01%
+25.0%
Q2 2019$1,186,000
-36.5%
498,1890.0%0.01%
-33.3%
Q1 2019$1,868,000
+4.5%
498,1890.0%0.01%
-20.0%
Q4 2018$1,788,000
-54.7%
498,189
-27.6%
0.02%
-42.3%
Q3 2018$3,943,000
-47.2%
688,075
-53.8%
0.03%
-53.6%
Q2 2018$7,466,000
-9.0%
1,490,201
-6.8%
0.06%
-20.0%
Q1 2018$8,203,000
-44.7%
1,598,991
-35.2%
0.07%
-45.3%
Q4 2017$14,825,000
+8.3%
2,466,7020.0%0.13%
+15.3%
Q3 2017$13,690,000
+19.6%
2,466,7020.0%0.11%
+11.0%
Q2 2017$11,445,000
-6.3%
2,466,7020.0%0.10%0.0%
Q1 2017$12,210,000
-55.4%
2,466,7020.0%0.10%
-62.7%
Q4 2016$27,380,000
+19.9%
2,466,7020.0%0.27%
+29.5%
Q3 2016$22,842,000
+60.5%
2,466,702
+10.0%
0.21%
+38.9%
Q2 2016$14,235,000
-2.6%
2,241,7020.0%0.15%
-3.2%
Q1 2016$14,616,000
-12.0%
2,241,702
+9.5%
0.15%
+11.6%
Q4 2015$16,601,000
+10.6%
2,046,9670.0%0.14%
-0.7%
Q3 2015$15,004,000
-28.5%
2,046,9670.0%0.14%
-24.5%
Q2 2015$20,981,000
+24.5%
2,046,967
+12.3%
0.18%
+31.4%
Q1 2015$16,853,000
+135.3%
1,821,967
+78.3%
0.14%
+91.8%
Q4 2014$7,161,000
+28.6%
1,021,6000.0%0.07%
+4.3%
Q3 2014$5,568,0001,021,6000.07%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$24,530,000,0003.64%
Opaleye Management Inc. 950,000$4,873,0001.39%
DSC Advisors, L.P. 1,187,604$6,092,0001.28%
DAFNA Capital Management LLC 335,500$1,721,0000.84%
Vivo Capital, LLC 855,000$4,386,0000.62%
Stonepine Capital Management, LLC 129,756$666,0000.36%
Eversept Partners, LP 107,500$551,4750.26%
Tekla Capital Management LLC 930,398$4,773,0000.19%
Perceptive Advisors 1,117,324$5,732,0000.16%
Crestline Management, LP 217,670$1,117,0000.14%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders